Biocept, Inc.
Biocept, Inc. (Biocept) is a privately-held biotechnology company. The company is engaged in the development of diagnostic assay products for life science research and in-vitro diagnostic markets. Biocept develops cell separation technology, an innovative class of diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. The company develops diagnostic products using its CEE technology to detect circulating ovarian cancer cells. In addition, the company entered into collaborations with several academic institutions and pharmaceutical to explore the application of the CEE system. The laboratory is accredited by the College of American Pathologists (CAP). Biocept is headquartered in California, the US.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

